Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice

Clinical Genetics
Elizabeth LobbN Hallowell

Abstract

There is accumulating evidence that women with breast cancer due to a familial BRCA1 or BRCA2 mutation benefit from specific surgical and chemotherapeutic treatment strategies. However, the rapid identification of such patients during the acute phase of treatment raises a number of issues. This study investigated Australian opinion leaders' views on the issues arising from such 'treatment-focused' genetic testing. Semi-structured interviews with 34 opinion leaders working in cancer genetics were undertaken. Interviewees acknowledged the introduction of treatment-focused DNA testing has the potential to positively transform the management of breast cancer patients, but were concerned that certain ethical and logistical issues have yet to be addressed. These include decision-making and consent, the familial nature of genetic information, and the management of genetics services within familial cancer clinics in the public hospital system in Australia. Service providers will need to have policies and strategies for managing the increased demand. It will also be necessary to include genetic counseling services within familial cancer clinics in the care pathway for newly diagnosed patients prior to any DNA testing to determine adjuva...Continue Reading

References

Aug 5, 1999·Journal of the National Cancer Institute·UNKNOWN Breast Cancer Linkage Consortium
Nov 8, 2001·Journal of the National Cancer Institute·L C HartmannR B Jenkins
Apr 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical Oncology
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical Oncology
Oct 24, 2003·Familial Cancer·G MitchellR A Eeles
Dec 10, 2003·Archives of Surgery·Jeffrey N WeitzelCarey A Cullinane
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly MetcalfeSteven A Narod
Apr 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lori J PierceBarbara L Weber
Aug 15, 2006·International Journal of Medical Sciences·Joseph A De Soto, Chu-Xia Deng
Jul 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sven RottenbergPiet Borst
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer E QuinnD Paul Harkin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.